Coping strategies and patient-reported outcomes (PROs) in early-phase cancer clinical trial (EP-CT) participants

被引:0
|
作者
Lundquist, Debra
Lam, Anh B.
Pelletier, Andrea
Durbin, Sienna
Petrillo, Laura A.
Jimenez, Rachel
Turbini, Victoria
Bame, Viola
Lynch, Kaitlyn
Yalala, Vaishnavi Reddy
Ollila, Nicholas
Malowitz, Benjamin
McIntyre, Casandra
Juric, Dejan
Nipp, Ryan David
机构
[1] Massachusetts Gen Hosp, Henri & Belinda Termeer Ctr Targeted Therapies, Boston, MA USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Massachusetts Gen Hosp, Boston, MA USA
[5] Univ Oklahoma, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e23194
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Associations of symptom burden with patient-reported outcomes (PROs) and clinical outcomes among early-phase cancer clinical trial (EP-CT) participants
    Lam, Anh B.
    Lundquist, Debra
    Pelletier, Andrea
    Durbin, Sienna
    Petrillo, Laura A.
    Jimenez, Rachel
    Turbini, Victoria
    Bame, Viola
    Lynch, Kaitlyn
    Yalala, Vaishnavi Reddy
    Ollila, Nicholas
    Malowitz, Benjamin
    McIntyre, Casandra
    Juric, Dejan
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Longitudinal changes in patient-reported outcomes (PROs) among early phase cancer clinical trial (EP-CT) participants
    Lundquist, Debra
    Pelletier, Andrea
    Durbin, Sienna
    Petrillo, Laura A.
    Jimenez, Rachel
    Turbini, Victoria
    Lam, Anh B.
    Bame, Viola
    Lynch, Kaitlyn
    Yalala, Vaishnavi Reddy
    Ollila, Nicholas
    Malowitz, Benjamin
    McIntyre, Casandra
    Juric, Dejan
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Identifying early-phase clinical trial (EP-CT) participants at risk for poor outcomes
    Lundquist, Debra
    Jimenez, Rachel
    Healy, Megan
    Johnson, Andrew
    Durbin, Sienna
    Capasso, Virginia
    McIntyre, Casandra
    Cashavelly, Barbara J.
    Juric, Dejan
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [4] Change in financial toxicity during early-phase cancer clinical trial (EP-CT) participation
    Durbin, Sienna
    Lundquist, Debra
    Pelletier, Andrea
    Petrillo, Laura A.
    Lam, Anh B.
    Jimenez, Rachel
    Turbini, Victoria
    Bame, Viola
    Lynch, Kaitlyn
    Yalala, Vaishnavi Reddy
    Ollila, Nicholas
    Malowitz, Benjamin
    McIntyre, Casandra
    Juric, Dejan
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [5] Financial toxicity, quality of life, symptom burden, and access to resources in early-phase clinical trial (EP-CT) participants
    Durbin, Sienna
    Lundquist, Debra
    Pelletier, Andrea
    Petrillo, Laura A.
    Bame, Viola
    Turbini, Victoria
    Heldreth, Hope
    Lynch, Kaitlyn
    McIntyre, Casandra
    Juric, Dejan
    Ferrell, Betty R.
    Jimenez, Rachel
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] The value of patient-reported outcomes in early-phase clinical trials
    Retzer, Ameeta
    Aiyegbusi, Olalekan Lee
    Rowe, Anna
    Newsome, Philip N.
    Douglas-Pugh, Jessica
    Khan, Sheeba
    Mittal, Saloni
    Wilson, Roger
    O'Connor, Daniel
    Campbell, Lisa
    Mitchell, Sandra A.
    Calvert, Melanie
    NATURE MEDICINE, 2022, 28 (01) : 18 - 20
  • [7] Patient-reported hope, quality of life, symptom burden, coping, and financial toxicity in early-phase clinical trial participants.
    Lundquist, Debra
    Pelletier, Andrea
    Durbin, Sienna
    Bame, Viola
    Turbini, Victoria
    Lynch, Kaitlyn
    Johnson, Andrew
    Heldreth, Hope
    Healy, Megan
    McIntyre, Casandra
    Juric, Dejan
    Jimenez, Rachel
    Ferrell, Betty R.
    Nipp, Ryan David
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 275 - 275
  • [8] The value of patient-reported outcomes in early-phase clinical trials
    Ameeta Retzer
    Olalekan Lee Aiyegbusi
    Anna Rowe
    Philip N. Newsome
    Jessica Douglas-Pugh
    Sheeba Khan
    Saloni Mittal
    Roger Wilson
    Daniel O’Connor
    Lisa Campbell
    Sandra A. Mitchell
    Melanie Calvert
    Nature Medicine, 2022, 28 : 18 - 20
  • [9] Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer
    Vilaplana, Andrea
    Morell, Mariona
    Valero-Arrese, Lorena
    Marshall, Lynley V.
    Salo, Anna
    Crowe, Tracey
    Romero, Laura
    de Rojas, Teresa
    Carceller, Fernando
    Moreno, Lucas
    PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
  • [10] Comment on: Incorporation of patient-reported outcomes in early-phase clinical trials for childhood and adolescent cancer
    Revon-Riviere, Gabriel
    Connolly, Denise
    Cohen-Gogo, Sarah
    PEDIATRIC BLOOD & CANCER, 2024,